Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,284 total articles
Palisade Bio, a clinical-stage biopharmaceutical company, announced its first quarter 2026 financial results and highlighted continued clinical progress of its lead PDE4 inhibitor prodrug PALI-2108 for treating inflammatory bowel disease (IBD). The company plans to initiate Phase 2 trials for ulcerative colitis in Q3 2026 and Crohn's disease in ear…
DoubleDown Interactive, a Nasdaq-listed digital games company, announced robust first quarter 2026 financial results with revenues increasing 12.7% year-over-year to $94.1 million and earnings per diluted share rising 48.4% to $14.28. Growth was driven by the integration of WHOW Games, expansion in Direct-to-Consumer revenue, and increased performa…
AnaptysBio completed the spin-off of its biopharma operations, First Tracks Bio, and now focuses solely on managing financial collaborations for Jemperli with GSK and imsidolimab with Vanda. The company anticipates exceeding $390 million annualized royalties from Jemperli by 2029 and benefits from GSK's expanding clinical trials and FDA designation…
Brookfield Bancshares, Inc., the holding company for First National Bank of Brookfield, has agreed to acquire NSTS Bancorp, Inc. in an all-cash transaction valued at $73.7 million. NSTS shareholders will receive $14.28 per share. The merger expands Brookfield's footprint in the Chicago-Naperville-Elgin metropolitan area, combining assets of over $6…
Global Ship Lease, a NYSE-listed containership owner and lessor, will release its first quarter 2026 financial results on May 22, 2026 before market open and conduct a related conference call and webcast. The company operates a fleet of 71 vessels and has substantial contracted revenue with an average charter term of 2.7 years weighted by TEU capac…
Public Policy Holding Company, Inc. announced robust Q1 2026 results highlighted by a 27.5% revenue increase to $50.1 million, driven by 5.1% organic growth and strategic acquisitions. Adjusted EBITDA rose 29.7% with a margin of 22.3%. The company reduced net debt to $1.8 million following its recent U.S. IPO and expanded its presence with addition…
Ring Energy, Inc. (NYSE American: REI) has commenced an underwritten public offering of $60 million of common stock with an option to sell an additional $9 million shares. The company plans to use the net proceeds primarily to repay borrowings under its senior secured credit facility and for general corporate purposes. The offering is subject to ma…
Sezzle Inc. announced a U.S. District Court ruling that allowed its core antitrust claims against Shopify to proceed while dismissing some tying claims without prejudice. The decision is procedural and does not imply liability, continuing the legal battle concerning alleged monopolization and restraint of trade.
Sun Country Airlines unveiled a special retro aircraft livery inspired by its 1994 design to celebrate its 43-year legacy and Minnesota roots. The livery honors co-founder Jim Olsen and reflects the airline's resilience through challenges. This announcement comes on the eve of Sun Country's acquisition by Allegiant Air, aiming for combined enhanced…
Spectral AI announced its Q1 2026 financial results highlighting ongoing development of its DeepView® System for burn indication with support from $31.7 million in BARDA funding under an accelerated contract phase. The company filed a De Novo 510(k) application with the FDA in June 2025 and is awaiting market authorization. Q1 showed a net loss pri…
Solid Biosciences reported Q1 2026 financial results highlighting key clinical progress in its Duchenne muscular dystrophy gene therapy SGT-003, including dosing the first participant in the Phase 3 IMPACT DUCHENNE trial. The company received Orphan drug designation from the European Commission and positive pediatric plan opinions from the EMA, sig…
Lumexa Imaging Holdings, Inc. announced its financial results for Q1 2026, showing a 3.1% increase in consolidated revenues to $252.5 million, a net income of $1.7 million reversing a prior year loss, and steady adjusted EBITDA of $51.2 million with a 20.3% margin. The company reported strong growth in advanced imaging volumes and is actively expan…
Stereotaxis announced its Q1 2026 financial results, highlighting FDA approvals for its MAGiC catheter and Synchrony digital OR system, ongoing commercial rollout, and a transformational acquisition of Robocath to enhance its robotic endovascular platform. While Q1 revenue declined slightly due to transition from legacy products, the company expect…
Black Rock Coffee Bar, Inc. announced its Q1 2026 financial results with total revenue increasing 23.7% year-over-year to $55.5 million and same store sales growth of 5.2%. The company opened 9 new stores during the quarter, contributing to strong operational performance. Net income turned positive at $1.8 million compared to a loss in the prior ye…
TELA Bio reported Q1 2026 revenue of $19.1 million, a 3% increase over the previous year, driven by robust international sales and product unit growth. The company launched OviTex LTR in the US, a fully resorbable hernia repair solution, and is expanding its European presence with 41% revenue growth. Despite a net loss increasing slightly to $12.3 …
Datadog, Inc., a leading AI-powered observability and security platform, announced that its management team will present at three prestigious investor conferences between May and June 2026. The presentations will be webcast live and later made available on the company's investor relations website.
Phillips Edison & Company, a leading US owner and operator of grocery-anchored neighborhood shopping centers, declared monthly dividend distributions of $0.1083 per common share payable in July and August 2026. Additionally, at their virtual annual meeting, all directors were re-elected, executive compensation was approved advisory-wise, and Deloit…
Mobile Infrastructure Corporation reported Q1 2026 financial results highlighting stable same-location revenue and a 4.4% increase in same-location net operating income (NOI), driven by improved parking utilization and contract volume growth. The company progressed in its $100 million asset rotation program with over $30 million in asset sales, use…
LB Pharmaceuticals announced Q1 2026 financial results and corporate updates highlighting initiation of pivotal Phase 3 trial for LB-102 in schizophrenia and Phase 2 trial in bipolar depression. The company secured $100 million in a private placement to fund operations into 2029, supporting multiple planned clinical readouts potentially unlocking s…
Reed's, Inc. reported a challenging first quarter of 2026 with net sales declining to $7.1 million from $10 million a year earlier, gross margin compression from 34% to 10%, and a net loss rising to $6.5 million. The company cited inventory rationalization, elevated SG&A expenses, and softer sales execution as key factors impacting results. Leaders…
High Roller Technologies announced strategic initiatives to launch ROLR-branded prediction markets in the U.S., backed by a definitive agreement with Crypto.com | Derivatives North America, strategic marketing partnerships, and enhanced applied AI capabilities. The company reported Q1 2026 revenues of $3.4 million, improved adjusted EBITDA, reduced…
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company focused on treating inflammatory diseases such as asthma and COPD, announced its management will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference. The company is advancing its lead drug candidate rademikibart, currently in global clini…
Bolt Biotherapeutics, a clinical-stage biopharmaceutical company focused on innovative cancer immunotherapies, reported its Q1 2026 financial results and business update. The company is advancing its lead product BDC-4182, a novel immune-stimulating antibody conjugate (ISAC) targeting claudin 18.2 for gastric and gastroesophageal cancers, with init…
Hour Loop, Inc., a U.S.-based online retailer, announced its Q1 2026 financial results showing a 16% year-over-year increase in net revenues to $29.9 million, with net income rising to $0.82 million. The company attributed revenue growth to expanded inventory availability and strong sales execution, despite a modest decline in gross margin due to h…
Surrozen, Inc., a biotechnology company specializing in targeted Wnt signaling therapeutics for ophthalmic diseases, announced that its management will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026. The presentation will be available via webcast and will outline the company's research, development plans, a…
